-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
19,116 Shares in Cutera, Inc. (NASDAQ:CUTR) Bought by Walleye Capital LLC
19,116 Shares in Cutera, Inc. (NASDAQ:CUTR) Bought by Walleye Capital LLC
Walleye Capital LLC bought a new position in shares of Cutera, Inc. (NASDAQ:CUTR – Get Rating) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 19,116 shares of the medical device company's stock, valued at approximately $1,319,000. Walleye Capital LLC owned about 0.11% of Cutera at the end of the most recent reporting period.
Several other institutional investors have also recently made changes to their positions in CUTR. Captrust Financial Advisors increased its holdings in Cutera by 592.2% in the first quarter. Captrust Financial Advisors now owns 533 shares of the medical device company's stock valued at $37,000 after buying an additional 456 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank purchased a new position in Cutera in the first quarter valued at $95,000. Everence Capital Management Inc. purchased a new position in Cutera in the first quarter valued at $218,000. Teacher Retirement System of Texas purchased a new position in Cutera in the first quarter valued at $220,000. Finally, SG Americas Securities LLC purchased a new position in Cutera in the first quarter valued at $233,000.
Get Cutera alerts:Cutera Stock Performance
CUTR opened at $48.89 on Friday. The firm has a market capitalization of $957.27 million, a PE ratio of -13.32 and a beta of 1.84. Cutera, Inc. has a twelve month low of $31.62 and a twelve month high of $74.38. The firm's 50-day moving average price is $46.67 and its 200 day moving average price is $49.29. The company has a current ratio of 4.36, a quick ratio of 3.83 and a debt-to-equity ratio of 12.56.
Cutera (NASDAQ:CUTR – Get Rating) last issued its earnings results on Thursday, August 4th. The medical device company reported ($0.24) EPS for the quarter, missing analysts' consensus estimates of ($0.23) by ($0.01). Cutera had a negative return on equity of 151.43% and a negative net margin of 27.62%. The firm had revenue of $64.22 million for the quarter, compared to analysts' expectations of $63.42 million. During the same period last year, the firm earned $0.39 earnings per share. Cutera's revenue for the quarter was up 9.6% on a year-over-year basis. As a group, sell-side analysts expect that Cutera, Inc. will post -1.88 EPS for the current fiscal year.Wall Street Analyst Weigh In
A number of research firms have weighed in on CUTR. Piper Sandler cut their price objective on shares of Cutera from $65.00 to $55.00 and set an "overweight" rating for the company in a report on Friday, August 5th. StockNews.com upgraded shares of Cutera to a "sell" rating in a research report on Friday, September 2nd. Maxim Group reiterated a "buy" rating and issued a $80.00 target price on shares of Cutera in a research report on Friday, August 5th. Finally, TheStreet lowered shares of Cutera from a "c-" rating to a "d+" rating in a research report on Thursday, July 7th.
Cutera Profile
(Get Rating)
Cutera, Inc, a medical device company, researches, develops, manufactures, markets, and services laser and energy-based aesthetics systems for practitioners worldwide. The company offers Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; excel V+, a vascular and benign pigmented lesion treatment platform; truSculpt iD, for the non-surgical body sculpting market; and Secret RF, a fractional RF microneedling system for tissue coagulation and hemostasis.
Featured Articles
- Get a free copy of the StockNews.com research report on Cutera (CUTR)
- 3 Banks Worth Considering For Q4
- Stock Market: 3 Islands Of Strength In A Sea Of Red
- Is There a Cure for What is Ailing Teladoc Stock?
- MarketBeat: Week in Review 9/12 – 9/16
- No One Told These 3 Stocks It's a Down Week
Want to see what other hedge funds are holding CUTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cutera, Inc. (NASDAQ:CUTR – Get Rating).
Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.
Walleye Capital LLC bought a new position in shares of Cutera, Inc. (NASDAQ:CUTR – Get Rating) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 19,116 shares of the medical device company's stock, valued at approximately $1,319,000. Walleye Capital LLC owned about 0.11% of Cutera at the end of the most recent reporting period.
根據Walleye Capital LLC在提交給美國證券交易委員會(SEC)的最新Form 13F文件中,該公司在第一季度購買了Cutera,Inc.(納斯達克代碼:CUTT-GET Rating)的新股票頭寸。該公司購買了19,116股這家醫療設備公司的股票,價值約1,319,000美元。在最近一次報告期結束時,Walleye Capital LLC擁有Cutera約0.11%的股份。
Several other institutional investors have also recently made changes to their positions in CUTR. Captrust Financial Advisors increased its holdings in Cutera by 592.2% in the first quarter. Captrust Financial Advisors now owns 533 shares of the medical device company's stock valued at $37,000 after buying an additional 456 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank purchased a new position in Cutera in the first quarter valued at $95,000. Everence Capital Management Inc. purchased a new position in Cutera in the first quarter valued at $218,000. Teacher Retirement System of Texas purchased a new position in Cutera in the first quarter valued at $220,000. Finally, SG Americas Securities LLC purchased a new position in Cutera in the first quarter valued at $233,000.
其他幾家機構投資者最近也改變了他們在Cutr的頭寸。CapTrust Financial Advisors在第一季度增持了592.2的Cutera股份。CapTrust Financial Advisors現在擁有533股這家醫療設備公司的股票,價值3.7萬美元,上個季度又購買了456股。Zurcher Kantonalbank蘇黎世廣東銀行在第一季度購買了Cutera的新頭寸,價值9.5萬美元。Everence Capital Management Inc.在第一季度購買了Cutera的一個新頭寸,價值21.8萬美元。德克薩斯州教師退休系統在第一季度購買了Cutera的一個新職位,價值22萬美元。最後,SG America Securities LLC在第一季度購買了Cutera的一個新頭寸,價值23.3萬美元。
Cutera Stock Performance
Cutera股票表現
CUTR opened at $48.89 on Friday. The firm has a market capitalization of $957.27 million, a PE ratio of -13.32 and a beta of 1.84. Cutera, Inc. has a twelve month low of $31.62 and a twelve month high of $74.38. The firm's 50-day moving average price is $46.67 and its 200 day moving average price is $49.29. The company has a current ratio of 4.36, a quick ratio of 3.83 and a debt-to-equity ratio of 12.56.
Cutr上週五開盤報48.89美元。該公司市值為9.5727億美元,市盈率為-13.32,貝塔係數為1.84。Cutera,Inc.的12個月低點為31.62美元,12個月高位為74.38美元。該公司的50日移動均線價格為46.67美元,200日移動均線價格為49.29美元。該公司的流動比率為4.36,速動比率為3.83,債務權益比率為12.56。
Wall Street Analyst Weigh In
華爾街分析師也加入進來
A number of research firms have weighed in on CUTR. Piper Sandler cut their price objective on shares of Cutera from $65.00 to $55.00 and set an "overweight" rating for the company in a report on Friday, August 5th. StockNews.com upgraded shares of Cutera to a "sell" rating in a research report on Friday, September 2nd. Maxim Group reiterated a "buy" rating and issued a $80.00 target price on shares of Cutera in a research report on Friday, August 5th. Finally, TheStreet lowered shares of Cutera from a "c-" rating to a "d+" rating in a research report on Thursday, July 7th.
一些研究公司已經對Cutr發表了看法。派珀·桑德勒將Cutera股票的目標價從65.00美元下調至55.00美元,並在8月5日星期五的一份報告中為該公司設定了“增持”評級。在9月2日星期五的一份研究報告中,StockNews.com將Cutera的股票評級上調至“賣出”。Maxim Group在8月5日(星期五)的一份研究報告中重申了對Cutera的評級,並對Cutera的股票發佈了80.00美元的目標價。最後,華爾街在7月7日星期四的一份研究報告中將Cutera的股票評級從C-下調至D+。
Cutera Profile
Cutera輪廓
(Get Rating)
(獲取評級)
Cutera, Inc, a medical device company, researches, develops, manufactures, markets, and services laser and energy-based aesthetics systems for practitioners worldwide. The company offers Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; excel V+, a vascular and benign pigmented lesion treatment platform; truSculpt iD, for the non-surgical body sculpting market; and Secret RF, a fractional RF microneedling system for tissue coagulation and hemostasis.
Cutera,Inc.是一家醫療器械公司,研究、開發、製造、營銷激光和基於能量的美學系統,併為全球從業者提供服務。該公司推出了Secret PRO,這是一種利用分數二氧化碳進行皮膚表面重塑和射頻微針進行深層真皮重塑的設備;truSculpt flex,一種生物電肌肉刺激設備,可以治療各種健康水平的患者;EXCEL V+,一種血管和良性色素病變治療平臺;truSculpt ID,用於非手術身體造型市場;Secret RF,一種用於組織凝固和止血的分數射頻微針系統。
Featured Articles
專題文章
- Get a free copy of the StockNews.com research report on Cutera (CUTR)
- 3 Banks Worth Considering For Q4
- Stock Market: 3 Islands Of Strength In A Sea Of Red
- Is There a Cure for What is Ailing Teladoc Stock?
- MarketBeat: Week in Review 9/12 – 9/16
- No One Told These 3 Stocks It's a Down Week
- 免費獲取StockNews.com關於Cutera的研究報告(Cutr)
- 第四季度值得考慮的3家銀行
- 股市:紅海中的三座強國
- 有什麼辦法可以治癒Teladoc股票的問題嗎?
- MarketBeat:回顧一週9/12-9/16
- 沒有人告訴這三隻股票這是下跌的一週
Want to see what other hedge funds are holding CUTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cutera, Inc. (NASDAQ:CUTR – Get Rating).
想看看其他對衝基金持有哪些Cutr嗎?訪問HoldingsChannel.com獲取Cutera,Inc.(納斯達克代碼:CUTT-GET Rating)的最新13F備案和內幕交易信息。
Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.
接受Cutera Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Cutera和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧